Lam Research Shares Down 5.2%, Sees Fourth Straight Quarter of Falling Sales in 2Q
By Ben Glickman
Shares of Lam Research fell after the company reported a third consecutive quarter of falling sales, a trend it expects to continue.
The stock was down 5.2% to $609.01 in after-hours trading on Wednesday, and was 1.2% lower at the close. The shares are up 53% this year.
Lam Research said after the market closed that it is forecasting a decline in second-quarter results, and reported a drop in first-quarter profit and revenue from a year ago.
The Fremont, Calif.-based chip-making equipment provider's shares were down despite posting results that surpassed analysts' estimates. Revenue in the first quarter sank 31% to $3.48 billion, above the $3.42 billion expected by analysts.
Lam's earnings have been dragged lower in recent quarters by a slump in the semiconductor industry.
Chief Executive Tim Archer said the company was seeing a "cyclically soft year" for customers' spending on Lam's equipment, but that the company was investing in future growth.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
October 18, 2023 19:30 ET (23:30 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks